TickerFactsScreenerDevelopers

Atea Pharmaceuticals, Inc. (AVIR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$7.91M2019: -$12.83M2020: $296.73M2021: -$87.00M2022: -$120.98M2023: -$85.39M2024: -$135.50M2025: -$132.03M-$132.03M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$132.03M+2.6%
2024-$135.50M-58.7%
2023-$85.39M+29.4%
2022-$120.98M-39.1%
2021-$87.00M-129.3%
2020$296.73M+2413.0%
2019-$12.83M-62.2%
2018-$7.91M—